메뉴 건너뛰기




Volumn 87, Issue 6, 2001, Pages 848-854

Safety of oral nicorandil before coronary artery bypass graft surgery

Author keywords

Cardiovascular system, effects; Heart, myocardial function; Pharmacology, nicorandil; Surgery, cardiopulmonary bypass

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENALIN; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EMLA; EPHEDRINE; FENTANYL; HEART ENZYME; HETASTARCH; HYDROXYZINE; ISOFLURANE; MIDAZOLAM; MORPHINE; NICARDIPINE; NICORANDIL; PANCURONIUM; PLACEBO; PROPACETAMOL; TRIMETAZIDINE; TROPONIN I; URAPIDIL; VASOACTIVE AGENT; VASODILATOR AGENT; VERAPAMIL;

EID: 17944377189     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/87.6.848     Document Type: Article
Times cited : (7)

References (28)
  • 1
    • 0027325609 scopus 로고
    • Safety profile of an anti-anginal agent with potassium channel opening activity: An overview
    • (1993) Eur Heart J , vol.14 , pp. 48-52
    • Roland, E.1
  • 11
    • 0029895234 scopus 로고    scopus 로고
    • Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate
    • (1996) Cardiovasc Res , vol.31 , pp. 941-946
    • Hide, E.J.1    Thiemermann, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.